Thu, Jul 24, 2014, 2:10 AM EDT - U.S. Markets open in 7 hrs 20 mins

Recent

% | $
Click the to save as a favorite.

Sarepta Therapeutics, Inc. Message Board

  • lindaj773966 lindaj773966 Nov 6, 2013 11:49 AM Flag

    As long as these short articles continue investors will have fear

    It's going to put a top for awhile until new data comes out by SRPT. These articles right or wrong will scare off longs. Sad but true. Manipulation on both sides.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think it's fair to say that there was some "irrational exuberance" in the entire biotech sector. It was a developing bubble that's now correcting. Not as bad as 1999-2000, but painful for those who came late to the zenith. "Risk off" for professional money managers has been happening now for a number of weeks, and it may over-correct on the downside. Biotech is now in a "show me the $$" mode; think REGN.

      In the biotech sector, even if initial data looks promising, what happened to ARIA is stark reminder of how things can go bad with drugs in Ph 3. Not saying this is the fate of SRPT, but the market is clearly not taking chances in this speculative arena. I think value will out with SRPT, it's just going to take longer b/c the FDA must maintain scientific scrutiny w/o favoritism towards drugs that appear to be safe. If you can afford to wait, this storm will pass, IMHO.

      Sentiment: Strong Buy

 
SRPT
21.35-0.53(-2.42%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.